Evidence map›Paper›PMID 34596728›Full record

ReviewImmunogenetics2022

Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.

Kuljeet Singh, Sachin Kumar, Sourabh Shastri, Amrit Sudershan, Vibhakar Mansotra

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Immunogenetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Current clinical status of new COVID-19 vaccines and immunotherapy.Environmental science and pollution research international · 2022
    Review
  12. Article
  13. Article
  14. Interpretation of data of case- sheets from COVID-19 ward.Journal of family medicine and primary care · 2022
    Article
  15. Review
  16. A Clinico-Demographic Study of Mucormycosis Cases Admitted in a Tertiary Care Government Hospital in Western Maharashtra.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kuljeet SinghDepartment of Computer Science & IT, University of Jammu, Jammu & Kashmir 180006, Jammu, India. kuljeetshan94@gmail.com.ORCID 0000-0003-2592-8625
Sachin KumarDepartment of Computer Science & IT, University of Jammu, Jammu & Kashmir 180006, Jammu, India.
Sourabh ShastriDepartment of Computer Science & IT, University of Jammu, Jammu & Kashmir 180006, Jammu, India.
Amrit SudershanInstitute of Human Genetics, University of Jammu, Jammu & Kashmir 180006, Jammu, India.
Vibhakar MansotraDepartment of Computer Science & IT, University of Jammu, Jammu & Kashmir 180006, Jammu, India.
University of Jammu · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The catastrophic phase of Covid-19 turns the table over with the spread of its disastrous transmission network throughout the world. Covid-19 associated with mucormycosis fungal infection accompanied by opportunistic comorbidities have emerged the myriad of complications and manifestations. We searched the electronic databases of Google Scholar, PubMed, Springer, and Elsevier until June 05, 2021, using keywords. We retrieved the details of confirmed and suspected mucormycosis patients associated with Covid-19. We analyzed the case reports, treatment given for Covid-19, steroids used, associated comorbidities, mucormycosis site involved, and patients survived or dead. Overall, 102 patients of mucormycosis associated with Covid-19 have been reported from India. Mucormycosis was predominant in males (69.6%) rather than females (19.6%), and most of the patients were active Covid-19 cases (70.5%). Steroids were mostly used (68.6%) for the treatment of Covid-19 followed by remdesivir (10.7%). Patients were suffering from diabetes mellitus (88.2%) and severe diabetic ketoacidosis (11.7%). Mucormycosis affects the sino-nasal (72.5%), orbit (24.5%), central nervous system (18.6%), and maxillary necrosis (13.7%) of the patients. The Mortality rate was recorded as 23.5%, and recovery rate was 2.9%. Diabetes mellitus cases are highest in India as compared to other countries, and prevalent use of steroids with the background of Covid-19 becomes an opportunistic environment for mucormycosis fungal infection to survive.

Indexed as

COVID-19Diabetes MellitusMucormycosisFemaleFungiHumansIndiaMaleSARS-CoV-2Black fungusCorticosteroidsCovid-19Diabetes mellitusMucormycosis

Identifiers

PMID34596728
PMCPMC8484850
OpenAlexW3203427824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.